Related Experiment Video
Updated: May 3, 2026

DUCT: Double Resin Casting followed by Micro-Computed Tomography for 3D Liver Analysis
Published on: September 28, 2021
Polycystic liver disease: ductal plate malformation and the primary cilium
Edgar S Wills1, Ronald Roepman2, Joost P H Drenth3
1Department of Medicine, Division of Gastroenterology and Hepatology, Radboud University Medical Centre, 6500 HB Nijmegen, The Netherlands; Department of Human Genetics, Radboud University Medical Centre, 6500 HB Nijmegen, The Netherlands.
Insights
Polycystic liver diseases, including autosomal dominant polycystic kidney disease (ADPKD) and isolated polycystic liver disease (PCLD), arise from genetic mutations. This review explores molecular drivers of hepatic cystogenesis and hepatobiliary development.
Area of Science:
- Hepatology
- Developmental Biology
- Genetics
Background:
- Polycystic livers are a hallmark of autosomal dominant polycystic kidney disease (ADPKD) and isolated polycystic liver disease (PCLD).
- ADPKD is primarily caused by mutations in PKD1 and PKD2, while PCLD involves PRKCSH or SEC63 mutations in 20% of cases.
- Cyst formation originates from ductal plate malformations driven by loss of heterozygosity in hepatoblasts, but the precise molecular mechanisms remain unclear.
Purpose of the Study:
- To review key factors in hepatobiliary development and identify molecular players involved in hepatic cystogenesis.
- To elucidate the underlying causes of polycystic liver diseases.
Main Methods:
- Literature review of recent advances in hepatobiliary organogenesis.
- Analysis of signaling pathways, transcriptional regulators, and cilium function in liver development and disease.
Main Results:
- Transforming growth factor (TGF)-β, Notch, and Wnt signaling pathways are crucial in hepatobiliary development.
- Transcriptional regulators like hepatocyte nuclear factor (HNF)6 and HNF1β play significant roles.
- Defects in primary cilium formation, including mutations or processing issues, are implicated in polycystic liver disease.
Conclusions:
- Understanding the molecular basis of hepatic cystogenesis requires integrating knowledge of developmental pathways and genetic factors.
- Further research into these pathways and cilium function is essential for developing targeted therapies for polycystic liver diseases.
Abstract:
Polycystic livers are found in autosomal dominant polycystic kidney disease (ADPKD), caused by polycystic kidney disease (PKD)1 and PKD2 mutations in virtually all cases, and in isolated polycystic liver disease (PCLD), where 20% of cases are caused by mutations in Protein kinase C substrate 80K-H (PRKCSH) or SEC63. Loss of heterozygosity in single hepatoblasts leads to underlying cystogenic ductal plate malformations. Crucially, actual components driving this development remain elusive. Recent advances have unraveled the roles of transforming growth factor (TGF)-β, Notch and Wnt signaling, transcriptional regulators such as hepatocyte nuclear factor (HNF)6 and HNF1β, as well as cilium function in hepatobiliary organogenesis. In polycystic liver disease, mutation or defective co-translational processing of key elements required for primary cilium formation have been implicated. This review recapitulates liver patterning factors in hepatobiliary development and extracts molecular players in hepatic cystogenesis.
Related Concept Videos
Microtubules in Signaling
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology

